This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1846 and based in Ewing, NJ , Church & Dwight Co., Inc. develops, manufactures and markets a broad range of household, personal care and specialty products. It is the leading U.S. producer of sodium bicarbonate, popularly known as baking soda, a natural product that cleans, deodorized, leavens and buffers. The company operates in six countries (Canada, Mexico, U.K., France, Australia and Brazil) and exports to over 90 other countries. Approximately 17% of the company’s net sales came from outside the U.S. in 2019. The company has 12 key brands, including ARM & HAMMER, Trojan, OxiClean, Spinbrush, First Response, Nair, Orajel, Xtra, L’IL CRITTERS and VITAFUSION, Waterpik, FLAWLESS and Batiste. The company’s ARM & HAMMER brand is one of the nation’s most trusted trademarks for a broad range of consumer and specialty products and its products are sold under ARM & HAMMER liquid and powder laundry detergent, ARM & HAMMER cat litter, ARM & HAMMER dental care and ARM & HAMMER baking soda. Markedly, eleven out twelve power brands were acquired by the company and added to its portfolio since 2001.
Church & Dwight (CHD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Newell (NWL) is Placed Just Ahead of Q1 Earnings
by Zacks Equity Research
Newell's (NWL) first-quarter 2024 performance is likely to have been hurt by a challenging macroeconomic environment and elevated levels of inflation.
Here's How Colgate (CL) Stock is Poised Ahead of Q1 Earnings
by Zacks Equity Research
Colgate's (CL) first-quarter 2024 performance is likely to gain from solid consumer demand and efforts related to innovation, premiumization and digital transformation.
Colgate (CL) to Retain Earnings Momentum in Q1: Wise to Buy?
by Zacks Equity Research
Colgate's (CL) aggressive pricing actions, along with solid business momentum, supported by robust consumer demand and innovation, should craft its successful earnings story.
Should You Buy Altria (MO) Ahead of Q1 Earnings Release?
by Zacks Equity Research
Despite facing several challenges, we maintain our belief in Altria's (MO) strong fundamentals and its potential for growth.
Helen of Troy (HELE) Q4 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Helen of Troy's (HELE) fourth-quarter performance is likely to reflect the adverse impact of pressured consumer spending. Persistent inflationary headwinds are a concern.
Keurig Dr Pepper's (KDP) Q1 Earnings Coming Up: What's in Store?
by Zacks Equity Research
Keurig Dr Pepper's (KDP) first-quarter 2024 results are likely to reflect gains from brand strength, significant pricing actions and a solid performance in its cold beverages.
Procter & Gamble (PG) Q3 Earnings Top Estimates, Sales Miss
by Zacks Equity Research
Procter & Gamble's (PG) Q3 results gain from sales growth across operating segments, improved organic sales and margin expansion, offset by higher SG&A expenses.
Can Boston Beer (SAM) Beat on Q1 Earnings Despite Cost Woes?
by Zacks Equity Research
Boston Beer's (SAM) Q1 results are expected to reflect gains from its focus on pricing, product innovation, growth of non-beer categories and brand development.
Kimberly-Clark (KMB) Q1 Earnings Coming Up: Is a Beat Likely?
by Zacks Equity Research
Kimberly-Clark's (KMB) first-quarter results are likely to reflect manufacturing cost inflation and volume concerns in some markets, while brand strength and the FORCE program are likely to have aided.
Here's Why PepsiCo (PEP) Looks Poised for Earnings Beat in Q1
by Zacks Equity Research
PepsiCo's (PEP) Q1 results are expected to reflect gains from continued benefits of the mitigation of inflationary pressures through cost-management and revenue-management initiatives.
Will Church & Dwight (CHD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Church & Dwight (CHD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why Church & Dwight (CHD) Appears to be a Promising Pick
by Zacks Equity Research
Church & Dwight (CHD) benefits from brand strength, efficient pricing and productivity gains. Favorable demand has been an upside.
Zacks Industry Outlook Highlights Colgate-Palmolive, Henkel, Church & Dwight and The Clorox
by Zacks Equity Research
Colgate-Palmolive, Henkel, Church & Dwight and The Clorox have been highlighted in this Industry Outlook article.
Tyson Foods (TSN) Rises More Than 20% in 6 Months: Here's How
by Zacks Equity Research
Tyson Foods' (TSN) engagement in brand building, innovation and operational enhancements positions it well despite the expected challenges in the Beef segment.
4 Soap & Cleaning Materials Stocks to Watch Amid Favorable Industry Trends
by Rajani Lohia
The soap and cleaning materials industry stays composed, backed by efforts to improve sales, including pricing actions, innovation, digital transformation and brand building, amid elevated costs. Players like CL, HENKY, CHD and CLX look well-poised.
Lamb Weston (LW) Readies for Q3 Earnings: What to Expect?
by Zacks Equity Research
Lamb Weston's (LW) third-quarter results are likely to reflect gains from pricing and capacity expansion endeavors amid cost and volume concerns.
Conagra Brands (CAG) Readies for Q3 Earnings: Is a Beat Likely?
by Zacks Equity Research
Conagra Brands' (CAG) third-quarter results are likely to reflect gains from innovation and the frozen category amid elevated cost concerns.
Here's Why RH's Earnings Are Likely to Decline Y/Y in Q4
by Zacks Equity Research
RH's fiscal Q4 results are likely to reflect high mortgage rates, a soft luxury housing market and clearance pressure.
Clorox (CLX) Benefits From Strategic and Pricing Efforts
by Zacks Equity Research
Clorox (CLX) benefits from pricing actions and cost-saving initiatives. The company also boasts a solid innovation pipeline.
Church & Dwight (CHD) Gains on Brand Strength Amid High Costs
by Zacks Equity Research
Church & Dwight (CHD) benefits from robust consumer demand, bolstered by consistent innovation, new product launches and strategic acquisitions. However, the company is seeing high marketing costs.
Archer Daniels (ADM) Announces Accelerated Share Repurchases
by Zacks Equity Research
Archer Daniels (ADM) announces an accelerated share repurchase agreement to buy back $1 billion of its common stock.
Archer Daniels (ADM) Q4 Earnings Beat, Revenues Dip Y/Y
by Zacks Equity Research
Archer Daniels (ADM) reports lower y/y sales in fourth-quarter 2023 due to a decline in sales across all segments.
Monster Beverage's (MNST) Growth Strategies Progress Well
by Zacks Equity Research
Monster Beverage (MNST) has been gaining from strength in its energy drinks category and product innovations.
Monster Beverage (MNST) Q4 Earnings Miss, Sales Rise Y/Y
by Zacks Equity Research
Monster Beverage (MNST) posts soft fourth-quarter 2023 results, wherein the top and bottom lines miss the Zacks Consensus Estimate.